Post Reply 
 
Thread Rating:
  • 0 Votes - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Double-blind, placebo-controlled study of L-carnosine supplementation in children
Author Message
James Offline
Administrator
*******

Posts: 2,827
Joined: Feb 2012
Reputation: 15
Post: #1
Double-blind, placebo-controlled study of L-carnosine supplementation in children
J Child Neurol. 2002 Nov;17(11):833-7.

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.

Chez MG1, Buchanan CP, Aimonovitch MC, Becker M, Schaefer K, Black C, Komen J.

Author information

Abstract

L-Carnosine, a dipeptide, can enhance frontal lobe function or be neuroprotective. It can also correlate with gamma-aminobutyric acid (GABA)-homocarnosine interaction, with possible anticonvulsive effects. We investigated 31 children with autistic spectrum disorders in an 8-week, double-blinded study to determine if 800 mg L-carnosine daily would result in observable changes versus placebo. Outcome measures were the Childhood Autism Rating Scale, the Gilliam Autism Rating Scale, the Expressive and Receptive One-Word Picture Vocabulary tests, and Clinical Global Impressions of Change. Children on placebo did not show statistically significant changes. After 8 weeks on L-carnosine, children showed statistically significant improvements on the Gilliam Autism Rating Scale (total score and the Behavior, Socialization, and Communication subscales) and the Receptive One-Word Picture Vocabulary test (all P < .05). Improved trends were noted on other outcome measures. Although the mechanism of action of L-carnosine is not well understood, it may enhance neurologic function, perhaps in the enterorhinal or temporal cortex.

http://www.MountainMistBotanicals.com
06-13-2015 05:59 PM
Find all posts by this user Quote this message in a reply
Post Reply 


Forum Jump:


User(s) browsing this thread: 1 Guest(s)